Company registration number: 10054014 Charity registration number: 1175161 

**ART FOR CURE TRUSTEES' REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2025** 

RDP Accountants 



## **Art For Cure Contents** 

||**Page**|
|---|---|
|Trustees' Report|1—2|
|Independent Examiner's Report|3|
|Statement of Financial Activities (including Income and Expenditure Account)|4|
|Balance Sheet|5|
|Notes to the Financial Statements|6—8|
|The following pages do not form part of the statutory accounts:||
|Detailed Statement of Financial Activities (including Income and Expenditure Account)|9|





**Art For Cure Company No. 10054014 Trustees' Report For The Year Ended 30 June 2025** 

The trustees present their report and the financial statements for the year ended 30 June 2025. 

## **Objectives and Activities** 

## **Aims and Objectives** 

Art For Cure is a nationally registered charity raising money (via Art for Cure Enterprises) through the sale of art, ceramics, and sculpture, grant-funding to leading breast cancer research in the UK and breast cancer support services. 

## **Public Benefit** 

The advancement of health and/or saving of lives. 

The trustees confirm that they have complied with the requirements of Section 17 of the Charities Act 2011 to have due regard to the Charity Commission’s guidance on public benefit. 

## **Reference and Administrative Details** 

## **Trustees** 

Mr Alexander Gray Dr Ilyena Froud Mr Nicholas Crocker Mrs Clare Burgess Mrs Belinda Gray 

## **Charity Number** 

1175161 

## **Company Number** 

10054014 

## **Independent Examiner** 

Simon Lasky FCCA RDP Accountants Unit D, Devon Suite Dencora Business Centre 36 Whitehouse Road Ipswich Suffolk IP1 5LT 

Page 1 



## **Art For Cure Trustees' Report (continued) For The Year Ended 30 June 2025** 

## **Small Company Rules** 

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006. 

trustees' report was approved by the board of trustees and signed on its behalf by: 

Mr Alexander Gray Trustee 10/03/2026 

Page 2 



## **Art For Cure Independent Examiner's Report to the Trustees of Art For Cure For The Year Ended 30 June 2025** 

I report to the charity trustees on my examination of the accounts of the Company for the year ended 30 June 2025. 

## **Responsibilities and Basis of Report** 

As the charity trustees of the Company (and also its directors for the purposes of company law), you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 (“the 2006 Act”). 

Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity’s accounts as carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act. 

## **Independent Examiner's Statement** 

Since the Company’s gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of The Association of Chartered Certified Accountants, which is one of the listed bodies. 

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe: 

1. accounting records were not kept in respect of the Company as required by section 386 of the 2006 Act; or 2. the accounts do not accord with those records; or 

3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fair view' which is not a matter considered as part of an independent examination; or 

4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102). 

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. 

Simon Lasky 

Simon Lasky FCCA 11/03/2026 Unit D, Devon Suite Dencora Business Centre 36 Whitehouse Road Ipswich Suffolk IP1 5LT 

Page 3 



## **Art For Cure Statement of Financial Activities (including Income and Expenditure Account) For The Year Ended 30 June 2025** 

|**Notes**<br>**INCOME AND ENDOWMENTS FROM:**<br>Donations and legacies<br>**3**<br>**EXPENDITURE ON:**<br>Raising funds<br>**4**<br>**NET INCOME/(EXPENDITURE)**<br>**NET MOVEMENT IN FUNDS**<br>**RECONCILIATION OF FUNDS:**<br>Total funds brought forward<br>**TOTAL FUNDS CARRIED FORWARD**<br>**10**|**2025**<br>**Unrestricted**<br>**funds**<br>**£**<br>273,272|**2024**<br>**Unrestricted**<br>**funds**<br>**£**<br>20,740|
|---|---|---|
||(238,446)|(174,805)|
||34,826|(154,065)|
||34,826<br>65,641|(154,065)<br>219,706|
||100,467|65,641|



The notes on pages 6 to 8 form part of these financial statements. 

Page 4 



**Art For Cure Balance Sheet As At 30 June 2025** 

|**Notes**<br>**FIXED ASSETS**<br>Investments<br>**7**<br>**CURRENT ASSETS**<br>Debtors<br>**8**<br>Cash at bank and in hand<br>**Creditors: Amounts Falling Due Within One Year**<br>**9**<br>**NET CURRENT ASSETS (LIABILITIES)**<br>**TOTAL ASSETS LESS CURRENT LIABILITIES**<br>**NET ASSETS**<br>**FUNDS OF THE CHARITY**<br>Unrestricted Funds<br>**TOTAL FUNDS**<br>**10**|**2025**<br>**Unrestricted**<br>**funds**<br>**£**<br>1|**2024**<br>**Total**<br>**funds**<br>**£**<br>1|
|---|---|---|
||1<br>58,716<br>42,335|1<br>62,292<br>3,830|
||101,051<br>(585)|66,122<br>(482 )|
||100,466|65,640|
||100,467|65,641|
||100,467|65,641|
||100,467|65,641|
||100,467|65,641|



For the year ending 30 June 2025 the charitable company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. 

The members have not required the charitable company to obtain an audit in accordance with section 476 of the Companies Act 2006. 

The trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. 

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime. 

On behalf of the board 


Mr Alexander Gray 

Trustee 10/03/2026 

The notes on pages 6 to 8 form part of these financial statements. 

Page 5 



**Art For Cure Notes to the Financial Statements For The Year Ended 30 June 2025** 

## 1. **General Information** 

Art For Cure is a company limited by guarantee, incorporated in England & Wales, registered number 10054014 and registered charity number 1175161. The registered office is . 

## 2. **Accounting Policies** 

## 2.1. **Basis of Preparation of Financial Statements** 

The financial statements have been prepared in accordance with the Charities SORP (FRS 102) "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)", Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. 

The charitable company is a Public Benefit Entity as defined by FRS 102. 

## 2.2. **Incoming Resources** 

Donations from A4C Enterprises, JustGiving and other individuals. 

## 2.3. **Resources Expended** 

Funds raised at art exhibitions and organised charity events are donated to vital UK researchers and East Anglian support services. 

## 2.4. **Investments** 

## 2.5. **Cash and Cash Equivalents** 

Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks, other short-term highly liquid investments that mature in no more than three months from the date of acquisition and are readily convertible to a known amount of cash with insignificant risk of change in value, and bank overdrafts. 

## 3. **Income from Donations and Legacies** 

||**2025**|**2024**|
|---|---|---|
||**Unrestricted**|**Unrestricted**|
||**funds**|**funds**|
||**£**|**£**|
|Donations and gifts|273,272|20,740|



## 4. **Analysis of Expenditure** 

|Raising funds<br>Raising funds|**Grant**<br>**funding of**<br>**activities**<br>**£**<br>237,576|**Support**<br>**costs**<br>(see note 5 )<br>**£**<br>870|**2025**<br>**Total**<br>**£**<br>238,446|
|---|---|---|---|
||**Grant**<br>**funding of**<br>**activities**<br>**£**<br>173,752|**Support**<br>**costs**<br>(see note 5 )<br>**£**<br>1,053|**2024**<br>**Total**<br>**£**<br>174,805|



Page 6 



## **Art For Cure Notes to the Financial Statements (continued) For The Year Ended 30 June 2025** 

5. **Support Costs** 

|5.<br> **Support Costs**|||
|---|---|---|
|General administration<br>General administration<br>6.<br> **Average Number of Employees**<br>Average number of employees during the year was: NIL (2024: NIL)<br>7.<br> **Investments**<br>**Cost or Valuation**<br>As at 1 July 2024<br>As at 30 June 2025<br>**Provision**<br>As at 1 July 2024<br>As at 30 June 2025<br>**Net Book Value**<br>As at 30 June 2025<br>As at 1 July 2024<br>8.<br> **Debtors**<br>**Due within one year**<br>Amounts owed by participating interests<br>9.<br> **Creditors: Amounts Falling Due Within One Year**<br>Trade creditors<br>Accruals and deferred income|**2025**<br>**£**<br>58,716<br>**2025**<br>**£**<br>-<br>585<br>585|**2025**<br>**Raising**<br>**funds**<br>**£**<br>870|
|||**2024**<br>**Raising**<br>**funds**<br>**£**<br>1,053|
|||**Subsidiaries**<br>**£**<br>1|
|||1|
|||-|
|||-|
|||1|
|||1|
|||**2024**<br>**£**<br>62,292|
|||**2024**<br>**£**<br>(1 )<br>483|
|||482|



Page 7 



## **Art For Cure Notes to the Financial Statements (continued) For The Year Ended 30 June 2025** 

## 10. **Movement in Funds** 

|**Unrestricted funds**<br>General:<br>General unrestricted fund<br>**Total funds**<br>**Unrestricted funds**<br>General:<br>General unrestricted fund<br>**Total funds**|**As at 1 July**<br>**2024**<br>**£**<br>65,641|**Income**<br>**£**<br>273,272|**Expenditure**<br>**£**<br>(238,446)|**As at 30**<br>**June 2025**<br>**£**<br>100,467|
|---|---|---|---|---|
||65,641|273,272|(238,446)|100,467|
||**As at 1 July**<br>**2023**<br>**£**<br>219,706|**Income**<br>**£**<br>20,740|**Expenditure**<br>**£**<br>(174,805)|**As at 30**<br>**June 2024**<br>**£**<br>65,641|
||219,706|20,740|(174,805)|65,641|



## 11. **Transactions with Trustees** 

None of the trustees received any remuneration or any other benefits from an employment with the charity or a related entity during the current or previous year. 

No trustee expenses have been incurred. 

## 12. **Related Party Disclosures** 

The charity received funds of £36,468 (2024 £16,863) from subsidiary company Art for Cure Enterprises Ltd 

## 13. **Company limited by guarantee** 

The company is limited by guarantee and has no share capital. 

Every member of the company undertakes to contribute to the assets of the company, in the event of a winding up, such an amount as may be required not exceeding £1. 

Page 8 



**Art For Cure Detailed Statement of Financial Activities (including Income and Expenditure Account) For The Year Ended 30 June 2025** 

|**INCOME AND ENDOWMENTS FROM:**<br>**Donations and legacies**<br>Donations and gifts<br>Donations from organisations<br>Crowd funding<br>**EXPENDITURE ON:**<br>**Raising funds**<br>Grants to institutions<br>Accountancy fees<br>Subscriptions<br>Bank charges<br>**NET INCOME/(EXPENDITURE)**|**2025**<br>**Total**<br>**funds**<br>**£**<br>15,174<br>36,468<br>221,630|**2024**<br>**Total**<br>**funds**<br>**£**<br>50<br>16,803<br>3,887|
|---|---|---|
||273,272|20,740|
||273,272<br>(237,576)<br>(768)<br>-<br>(102)|20,740<br>(173,752)<br>(483)<br>(486)<br>(84)|
||(238,446)|(174,805)|
||(238,446)|(174,805)|
||34,826|(154,065)|



Page 9 




## **Issuer** 

**Issuer** RDP Accountants **Document generated** Tue, 10th Mar 2026 17:40:32 GMT **Document fingerprint** 677766b1bc2f618a5edd97a244466ab5 

## **Parties involved with this document** 

**Document processed Party + Fingerprint** Tue, 10th Mar 2026 18:09:08 GMT Mr Alexander James Gray  - Signer (bcc965267c941b9f1c38f74bdb7b85e5) Wed, 11th Mar 2026 8:49:43 GMT Simon Lasky - Signer (e7e2ef4c96a05399c3ad86a97e6b2fbc) Wed, 11th Mar 2026 8:49:43 GMT Hub Administrator - Copied In (49a14258c6f21c87aa95e46c73802c03) 

## **Audit history log** 

**Date Action** Tue, 10th Mar 2026 17:40:32 GMT Envelope generated with fingerprint 21566d56085dbe5d4b6152854c79a280 (18.133.63.166) Tue, 10th Mar 2026 17:40:32 GMT Document generated with fingerprint 677766b1bc2f618a5edd97a244466ab5. (18.133.63.166) Tue, 10th Mar 2026 17:40:32 GMT Document generated with fingerprint 14bf224ee8620764a5dd8a61735eaacf. (18.133.63.166) Tue, 10th Mar 2026 17:40:32 GMT Mr Alexander James Gray  has been assigned to this envelope. (18.133.63.166) Tue, 10th Mar 2026 17:40:32 GMT Simon Lasky has been assigned to this envelope. (18.133.63.166) Tue, 10th Mar 2026 17:40:32 GMT Hub Administrator has been assigned to this envelope. (18.133.63.166) Tue, 10th Mar 2026 17:40:32 GMT Envelope has been set to automatically remind the active signer every 7 day(s). (18.133.63.166) 

Tue, 10th Mar 2026 17:40:38 GMT Tue, 10th Mar 2026 17:40:38 GMT Tue, 10th Mar 2026 17:40:38 GMT Tue, 10th Mar 2026 18:08:18 GMT Tue, 10th Mar 2026 18:09:08 GMT Tue, 10th Mar 2026 18:09:08 GMT Tue, 10th Mar 2026 18:09:08 GMT Wed, 11th Mar 2026 8:48:55 GMT 

Envelope generated 

Sent the envelope to Mr Alexander James Gray for signing Document emailed to party email 

Mr Alexander James Gray  viewed the envelope (86.161.155.172) Mr Alexander James Gray  signed the envelope (86.161.155.172) Sent the envelope to Simon Lasky for signing (86.161.155.172) 

Document emailed to party email 

Simon Lasky viewed the envelope (90.217.248.162) 



Wed, 11th Mar 2026 8:49:43 GMT Wed, 11th Mar 2026 8:49:43 GMT Wed, 11th Mar 2026 8:49:43 GMT Wed, 11th Mar 2026 8:49:43 GMT Wed, 11th Mar 2026 8:49:43 GMT Wed, 11th Mar 2026 8:49:43 GMT Wed, 11th Mar 2026 8:49:43 GMT 

Wed, 11th Mar 2026 8:49:44 GMT 

Simon Lasky signed the envelope (90.217.248.162) Sent the envelope to Hub Administrator for signing (90.217.248.162) This envelope has been signed by all parties (90.217.248.162) Signed document confirmation emailed to party email (90.217.248.162) Signed document confirmation emailed to party email (90.217.248.162) Signed document confirmation emailed to party email (90.217.248.162) Signed document confirmation emails have been sent to all parties. Document URL: 

https://api.signable.app/shareable/envelope?t=a60dd894-58e6-4fb7-8115-4 fa22377e425 (90.217.248.162) Document emailed to party email 

